Towards implementation of pharmacogenomics-guided therapy in patients with mental illness - Stage Preliminary (P) and Stage 1 (ENACT)

Not Applicable

Completed

• Conditions: Major Depressive Disorder; Anxiety Disorders; Mental Health - Other mental health disorders; Mental Health - Anxiety

• Registration Number: ACTRN12621000739819
• Lead Sponsor: St Vincent's Hospital Clinical Genomics

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-06-11
• Study Completion: 2022-02-21
• Last Update Posted: 23 May 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 188

Inclusion Criteria

Patient re-contact (Stage P):
•Adult patients aged 18 years or older
•Previously had PG testing arranged through SVCG or at another clinical genomic clinic
•Understands spoken and written English
•Willingness to give implied consent, and willingness to participate in and answer specific survey questions

Clinician (Stage P):
•Registered clinicians involved in the current care of the patients who had PG testing
•Willingness to give implied consent, and willingness to participate in and answer specific survey questions

Clinician (Stage 1):
•Clinicians, including specialists, registrars, residents, and clinical nurse consultants/practitioners, who are employed by the Departments of Psychiatry and Pharmacy at St Vincent’s Hospital Sydney (SVHS) or at recruited external institutions
•Willingness to give verbal consent, and willingness to participate in and answer specific interview/survey questions

Exclusion Criteria

Unwilling to participate in study

Study & Design

• Study Type: Observational
• Study Design: Not specified